Oramed Pharmaceuticals Inc. (ORMP) News Nov 20, 2014, 3:58

New Post Public Reply Private Reply Replies (0) Message Board
Savant
Oramed Pharmaceuticals Inc. (ORMP) News Nov 20, 2014, 3:58 p.m.
MarketWatch News on ORMP
Oramed's oral insulin tests are positive, but investors are skittish 2:17 p.m. Jan. 30, 2014 - Russ Britt
Twitter, Tesla surge; BlackBerry slips 4:22 p.m. Dec. 26, 2013 - Wallace Witkowski
Oramed gets FDA approval for flagship drug plans 9:04 a.m. May 17, 2013 - MarketWatch.com

Other News on ORMP
10-K: ORAMED PHARMACEUTICALS INC. 10:10 a.m. Nov. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Israeli Biotech Stocks Offer Low Returns For High Risk Investment 7:12 a.m. Oct. 3, 2014 - Seeking Alpha
New Diabetes Drugs Gain Approval - Florins Versus Oral Insulin 1:15 p.m. Sept. 14, 2014 - Seeking Alpha
10-Q: ORAMED PHARMACEUTICALS INC. 2:40 p.m. July 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Traders taking positions ahead of Oramed's presentations 3:03 p.m. June 11, 2014 - Seeking Alpha
The Importance Of Being Oral 5:32 p.m. June 3, 2014 - Seeking Alpha
Does Oramed Pharmaceuticals Pass The Smell Test? 11:06 a.m. May 23, 2014 - Seeking Alpha
10-Q: ORAMED PHARMACEUTICALS INC. 1:42 p.m. April 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Oramed Can Benefit As MannKind Opens The Diabetes Market For Novel Drugs 10:01 a.m. April 8, 2014 - Seeking Alpha
Oramed gets roughed up 12:16 p.m. March 12, 2014 - Seeking Alpha
Shots fired at Oramed in NY Observer 12:11 p.m. Feb. 26, 2014 - Seeking Alpha
Oramed submits phase 2a protocol to FDA for diabetes treatment, +14% 3:29 p.m. Feb. 10, 2014 - Seeking Alpha
The Dream Of The Insulin Pill: Oramed Vs. Rivals 6:51 a.m. Feb. 6, 2014 - Seeking Alpha
Oramed sinks after trial results criticized 10:13 a.m. Feb. 3, 2014 - Seeking Alpha
Oramed insulin capsule hits trial goals 7:16 a.m. Jan. 30, 2014 - Seeking Alpha
Oramed's Data Will Define A New Standard For Diabetes 7:48 a.m. Jan. 28, 2014 - Seeking Alpha
3 Small Biotech Companies Poised For Big Growth In 2014 1:07 p.m. Jan. 21, 2014 - Seeking Alpha
Six Israeli Biotech New Issues Set A Blistering Pace 5:12 p.m. Jan. 14, 2014 - Investors Business Daily
10-Q: ORAMED PHARMACEUTICALS INC. 3:35 p.m. Jan. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Aegis sees further upside for Oramed after big run 11:02 a.m. Jan. 8, 2014 - Seeking Alpha

Press Releases on ORMP
Coverage Initiation Report Focuses on Oramed Pharmaceuticals 8:46 a.m. Nov. 11, 2014 - Marketwired
Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 7:25 a.m. Oct. 31, 2014 - PR Newswire - PRF
Oramed to Present at the FireRock Annual Micro-Cap Conference 7:25 a.m. Oct. 24, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 7:29 a.m. Oct. 22, 2014 - PR Newswire - PRF
Oramed to Present at Family Office & Wealth Management Conference 7:15 a.m. Sept. 15, 2014 - PR Newswire - PRF
Oramed's Insulin Pill Superior to New Diabetes Drugs Gaining Approval 7:01 a.m. Sept. 11, 2014 - ACCESSWIRE
Oramed to Present at Upcoming Conferences 7:15 a.m. Sept. 3, 2014 - PR Newswire - PRF
Oramed Granted Patent in Spain for Oral Administration of Insulin 7:15 a.m. Aug. 19, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals Reports Last Patient Out in Phase IIa Trial for ORMD-0801 in Type 1 Diabetes 7:20 a.m. Aug. 7, 2014 - PR Newswire - PRF
Type 2 Diabetes Global Clinical Trials Review, H1, 2014 2:31 p.m. July 15, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals to Present at the BIO International Convention in San Diego 7:15 a.m. June 23, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals to Present at the American Diabetes Association 74th Scientific Sessions on June 13 - 17, 2014 in San Francisco 7:15 a.m. June 10, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals Added to the Morgan Stanley Capital International (MSCI) MicroCap Index 11:00 a.m. May 29, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals to Present at the IATI Israel Innovation Conference in Tel Aviv 6:00 a.m. May 19, 2014 - PR Newswire - PRF
Oramed to Present Poster on its Oral Insulin Capsule at the Yale Diabetes Symposium 12:10 p.m. May 13, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals Presents Data from Phase IIa Trial with ORMD-0801 in Type 2 Diabetes at the 2014 Diabetes Summit 1:30 p.m. April 24, 2014 - PR Newswire - PRF
Oramed Granted Patent in Hong Kong for Oral Administration of Insulin 7:10 a.m. April 10, 2014 - PR Newswire - PRF
Oramed Pharmaceuticals Announces First Patient Enrolled in a US Phase 2a Trial for ORMD-0801 in Treatment of Type 1 Diabetes 7:45 a.m. March 27, 2014 - PR Newswire - PRF
LifeSci Advisors Initiates Coverage of Oramed Pharmaceuticals 8:31 a.m. March 20, 2014 - Marketwire
Oramed Granted its 3rd Patent in Australia for Oral Administration of Exenatide 7:30 a.m. March 11, 2014 - PR Newswire - PRF

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking Real-Time Video Solutions with Haivision on AWS

Updated Category News Views 90

Haivision StreamHub and MoJoPro Revolutionize Mobile Broadcasting Haivision Systems Inc. (TSX: HAI), a leader in real-time video networking, has launched an innovative mobile broadcasting solution. Now available on the AWS Marketplace, the pairing of Haivision StreamHub with the MoJoPro app changes the game for journalists, video professionals, and broadcasters. They can...

Continue Reading
Keurig Dr Pepper's Strategic Acquisition Plans for JDE Peet's

Updated Category News Views 298

Keurig Dr Pepper's Strategic Acquisition Plans for JDE Peet's In a noteworthy announcement, Keurig Dr Pepper Inc. (NASDAQ: KDP) and JDE Peet's N.V. are making headlines with their plans regarding a public offer. This joint statement serves to inform stakeholders about the progress on KDP's intended recommended public offer for all outstanding shares of JDE Peet's. Basis...

Continue Reading
Join Wreaths Across America: Make a Difference This Season

Updated Category News Views 93

Join Wreaths Across America This December This December, Wreaths Across America (WAA), a national nonprofit, is gearing up for a meaningful wreath season. With over 20 new loads in need of carrier support, WAA is on the lookout for dedicated carriers and professional drivers who want to take part in its mission to Remember, Honor, and Teach. This initiative is set to...

Continue Reading
iMD Companies to Introduce New Product Line for Supplements

Updated Category News Views 159

iMD Companies and Riize Health Launch New Supplements iMD Companies, Inc. (OTC: ICBU) and its subsidiary, Riize LLC, are making waves in the health sector by introducing three new non-prescription products designed for online and retail distribution. The launch is set for the first quarter of the upcoming year and aims to cater directly to consumer needs in the...

Continue Reading
Activist Investors Surge: A Look into 2025's Landscape

Updated Category News Views 1737

Activist Investors Surge in 2024 By Svea Herbst-Bayliss A remarkable shift occurred in 2024 as a record number of activist shareholders launched campaigns aimed at global companies. Recent reports highlight that tactics employed by these shareholders have yielded impressive returns, which suggests a continued rise in these activities as we progress into the future. Rising...

Continue Reading